Who could be the various party looking at API business?? anyone want to have a guess?
Personally i think CML is high on the list consider they want to expand their business and phamarcy is one of the key growth they have been looking at for the last couple of yrs. Consider WOW is a main competitor of CML and it took a slice of WHS, so I wouldnt think CML will want to lag behind WOW. API is great way to get into the pharmaceutial business and its sp has suffered abit downturn so make it quite a bargain. Wouldnt be surprise if CML has been accummulated and hasnt disclose to asx yet.
my 2 cent worth.
any other thoughts???
API Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held